Vasculitis: current status and future directions.
Vasculitides represent such a heterogeneous group of disorders that difficulties arise in their classification. Although biopsy examination of involved tissues remains essential, new serological markers have been developed. Therapeutic strategies have been refined, and B lymphocyte-targeted drugs may prove a satisfactory alternative.
Youinou
Pierre
P
Laboratory of Immunology, Brest University Medical School Hospital, Brest, France. youinou@univ-brest.fr
D000818:Animals; D006801:Humans; D014657:Vasculitis / Q000145:classification / Q000209:etiology / Q000628:therapy*